• 17629 Citations
  • 62 h-Index
1975 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Robert F Gagel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Calcitonin Medicine & Life Sciences
Multiple Endocrine Neoplasia Type 2a Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pheochromocytoma Medicine & Life Sciences
Calcitonin Gene-Related Peptide Medicine & Life Sciences
Mutation Medicine & Life Sciences
Multiple Endocrine Neoplasia Medicine & Life Sciences
Proto-Oncogenes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1975 2019

1 Citation (Scopus)
Calcitonin
Incidence
Serum
Placebos
exenatide
2 Citations (Scopus)
Kruppel-Like Transcription Factors
Protein-Tyrosine Kinases
Proteolysis
Cell Death
Apoptosis
1 Citation (Scopus)

Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer

Sinha, K. M., Bagheri-Yarmand, R., Lahiri, S., Lu, Y., Zhang, M., Amra, S., Rizvi, Y., Wan, X., Navone, N., Ozpolat, B., Logothetis, C., Gagel, R. F. & Huard, J., Jun 20 2019, In : Oncogene. 38, 25, p. 5038-5049 12 p.

Research output: Contribution to journalArticle

Histone Demethylases
Castration
Prostatic Neoplasms
Epigenomics
Genes
1 Citation (Scopus)

Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease

Liu, H., He, J., Koh, S. P., Zhong, Y., Liu, Z., Wang, Z., Zhang, Y., Li, Z., Tam, T. K. B., Lin, P., Xiao, M., Young, K. H., Amini, B., Starbuck, M. W., Lee, H. C., Navone, N. M., Davis, R. E., Tong, Q., Bergsagel, P. L., Hou, J. & 4 others, Yi, Q., Orlowski, R., Gagel, R. F. & Yang, J., Jan 1 2019, In : Science Translational Medicine. 11, 494, eaau9087.

Research output: Contribution to journalArticle

Bone Diseases
Adipocytes
Bone Marrow
Peroxisomes
Polycomb Repressive Complex 2
1 Citation (Scopus)

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

Hu, M. I-N., Elisei, R., Dedecjus, M., Popovtzer, A., Druce, M., Kapiteijn, E., Pacini, F., Locati, L., Krajewska, J., Weiss, R. & Gagel, R. F., Feb 1 2019, In : Endocrine-Related Cancer. 26, 2, p. 241-250 10 p.

Research output: Contribution to journalArticle

Safety
Asthenia
Hypokalemia
Hypocalcemia
Random Allocation